Today it was reported that a Director at Staar Surgical Company (STAA), John C. Moore, exercised options to buy 7,500 STAA shares at $1.92 a share, for a total transaction value of $14.4K. The options were close to expired and John C. Moore retained stocks.
Following John C. Moore’s last STAA Buy transaction on May 24, 2016, the stock climbed by 22.4%. Following this transaction John C. Moore’s holding in the company was increased by 5.78% to a total of $3.78 million.
See today’s analyst top recommended stocks >>
Based on Staar Surgical Company’s latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $32.58 million and quarterly net profit of $1.37 million. In comparison, last year the company earned revenue of $27.09 million and had a net profit of $583K. STAA’s market cap is $1.22B and the company has a P/E ratio of 218.60. Currently, Staar Surgical Company has an average volume of 662.2K.
Starting in June 2018, STAA received 12 Buy ratings in a row.
The insider sentiment on Staar Surgical Company has been positive according to 12 insider trades in the past three months. This sentiment is slightly higher than the average sentiment of company insiders in this sector.
John C. Moore’s trades have generated a 74.6% average return based on past transactions. DailyInsider proprietary algorithm detects trades by the most influential insiders and selects attractive trading opportunities daily. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
STAAR Surgical Co. engages in the development, manufacture, production, market, and trade of implantable lenses for the eye and delivery systems. It specializes in refractive and cataract solutions. Its products include intraocular lens and implantable collamer lens. The company was founded in 1982 and is headquartered in Monrovia, CA.
